Navigation Links
Pfizer Announces EMPHASIS-HF Trial to Halt Recruitment due to Significant Benefit Observed in Patients Treated With Inspra® (Eplerenone)
Date:5/27/2010

This release contains forward-looking information about a potential additional indication for Inspra, including its potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; decisions by regulatory authorities regarding whether and when to approve any supplemental drug applications that may be filed for this additional indication for Inspra as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of any such additional indication; and competitive developments.

A further list and description of risks and uncertainties can be found in Pfizer's Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.


'/>"/>
SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish
2. Oramed Pharmaceuticals Announces That Dr. Michael Berelowitz, Senior Vice President at Pfizer, Joins its Board of Directors
3. Pfizer Global Manufacturing Announces Plans to Reconfigure Its Global Plant Network
4. Anavex comments on failure of Pfizer and Medivations Alzheimers investigational drug Dimebon during Phase 3 clinical trials
5. Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting
6. Pfizer Global R&D Presents 2008 Top Intermediates CMO Award to Asymchem
7. GSK and Pfizer Innovative Agreement Creates Specialist HIV Company
8. Lakewood-Amedex, Inc. Appoints William J. Robison, Former Executive Vice President of Pfizer, as Board Member
9. MannKind Agrees with Pfizer on the Purchase of Frankfurt Insulin Manufacturing Plant
10. JMAR Technologies' Chief Scientist Invited by Pfizer Inc. to Speak at IFPAC -- BioSentry Makes Strides in Pharma Market
11. Hovione Buys Pfizers Loughbeg API Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014 Amgen (NASDAQ: AMGN ) ... $0.61 per share dividend for the third quarter of ... 2014, to all stockholders of record as of the ... About Amgen Amgen is committed to unlocking the ... by discovering, developing, manufacturing and delivering innovative human therapeutics. ...
(Date:7/25/2014)... 2014 According to a new market ... - Global Industry Analysis, Size, Share, Growth, Trends and ... is estimated at USD 161,056.5 million in 2014 and ... from 2014 to 2020, to reach an estimated value ... drugs market is witnessing a significant growth due to ...
(Date:7/25/2014)... 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... development and commercialization of a once-daily, oral therapy for ... announced financial results for the period ended June 30, ... , Reported cash and cash equivalents totaling $37.4 million ... 31, 2013.  , Reported a net loss of ...
(Date:7/24/2014)... NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. ... the long-term, randomized, active control Phase 3 study of ... phosphate binder, for the treatment of hyperphosphatemia in patients ... study (PhosphatE binding and iRon delivery with FErric CiTrate ... Journal of the American Society of Nephrology ( ...
Breaking Biology Technology:Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4
... of Wisconsin-Milwaukee (UWM) have discovered an entirely new ... kid" of the carbon family, graphene. The discovery, ... pushes carbon materials closer to ushering in next-generation ... that resembles a flat sheet of chicken wire ...
... Calif., April 16, 2012 WaferGen Bio-systems, Inc. ... a strategic realignment and new direction for the ... customers to perform accurate high-throughput qPCR projects for ... sequencing in a simpler and more cost-effective way.  ...
... MOORESVILLE, N.C., April 13, 2012 A recent solicitation ... Iosat Potassium Iodide has created a deluge of orders ... for troop support, the 130mg tablets provide protection against ... International concerns about the development of nuclear weaponry in ...
Cached Biology Technology:UWM discovery advances graphene-based electronics 2UWM discovery advances graphene-based electronics 3WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment 2WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment 3Potassium Iodide Sales Surge on Heels of Large Government Order 2
(Date:7/28/2014)... DUBLIN , July 28, 2014 ... the "Biometrics Market in Latin America 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Biometrics measure and analyze biological ... facial patterns, irises, eye retinas, voice patterns, and hand ... one or more stored templates. The main purpose of ...
(Date:7/28/2014)... Engineering at Harvard University today announced that its ... newly formed private company to accelerate development of ... The announcement follows a worldwide license agreement ... the start-up Emulate Inc., relating to the use ... , "This is a big win towards achieving ...
(Date:7/27/2014)... has revealed that nicotine and cotinine, a metabolite of ... certain carcinogen in smoke. , The carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or ... and ultimately ends up in the tobacco smoke. Once ... where it is activated by a variety of enzymes ... revealed that nicotine can partially interfere with the activation ...
Breaking Biology News(10 mins):Biometrics Market in Latin America 2014-2018 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 3Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2
... climate change, researchers at BBSRC-supported Rothamsted Research have shown. ... aphid (Myzus persicae) has been found to be flying ... for January and February combined. This year, the first ... weeks ahead of the 42-year average. This work is ...
... the hundreds of species of woody vines that University of ... of Panama, the largest has a stalk nearly 20 inches ... Schnitzer. "And because it winds itself up to the forest ... as a community of trees." Such vines, called lianas, ...
... health care, computational biology, homeland security and other areas, ... proven cumbersome and difficult. An emerging research field known ... such mountains of information to find and put together ... of Technology has received a five-year grant to lead ...
Cached Biology News:Aphids are sentinels of climate change 2Vine invasion? UWM ecologist looks at coexistence of trees and lianas 2Vine invasion? UWM ecologist looks at coexistence of trees and lianas 3Grant supports emerging field of massive data analysis and visual analytics 2Grant supports emerging field of massive data analysis and visual analytics 3Grant supports emerging field of massive data analysis and visual analytics 4
... Cell Invasion Assay is designed to determine ... as a significant barrier to invasion or ... in a convenient, high-throughput, 96-well format. The ... all types of adherent cells such as ...
... design in ice/water bath This CLS ... created to easily match Cornings product ... please order under the old Sigma-Aldrich ... for assistance. ID clarifier: rack and ...
Membrane Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
Biology Products: